Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy.

BACKGROUND: Both induction chemotherapy followed by irradiation and concurrent chemotherapy and radiotherapy have been reported as valuable alternatives to total laryngectomy in patients with advanced larynx or hypopharynx cancer. We report results of the randomized phase 3 trial 24954 from the European Organization for Research and Treatment of Cancer. METHODS: Patients with resectable advanced squamous cell carcinoma of the larynx (tumor stage T3-T4) or hypopharynx (T2-T4), with regional lymph nodes in the neck staged as N0-N2 and with no metastasis, were randomly assigned to treatment in the sequential (or control) or the alternating (or experimental) arm. In the sequential arm, patients with a 50% or more reduction in primary tumor size after two cycles of cisplatin and 5-fluorouracil received another two cycles, followed by radiotherapy (70 Gy total). In the alternating arm, a total of four cycles of cisplatin and 5-fluorouracil (in weeks 1, 4, 7, and 10) were alternated with radiotherapy with 20 Gy during the three 2-week intervals between chemotherapy cycles (60 Gy total). All nonresponders underwent salvage surgery and postoperative radiotherapy. The Kaplan-Meier method was used to obtain time-to-event data. RESULTS: The 450 patients were randomly assigned to treatment (224 to the sequential arm and 226 to the alternating arm). Median follow-up was 6.5 years. Survival with a functional larynx was similar in sequential and alternating arms (hazard ratio of death and/or event = 0.85, 95% confidence interval = 0.68 to 1.06), as were median overall survival (4.4 and 5.1 years, respectively) and median progression-free interval (3.0 and 3.1 years, respectively). Grade 3 or 4 mucositis occurred in 64 (32%) of the 200 patients in the sequential arm who received radiotherapy and in 47 (21%) of the 220 patients in the alternating arm. Late severe edema and/or fibrosis was observed in 32 (16%) patients in the sequential arm and in 25 (11%) in the alternating arm. CONCLUSIONS: Larynx preservation, progression-free interval, and overall survival were similar in both arms, as were acute and late toxic effects.

Dieu obscur : le sexe, la cruauté et la violence dans l'Ancien Testament

Le Dieu de l'Ancien Testament peut choquer les lecteurs de la Bible : il noie sa création sous le déluge, il exige d'Abraham qu'il sacrifie son fils, il élimine les premiers-nés des Egyptiens la nuit précédant l'exode ou supprime impitoyablement les Israélites qui s'étaient adonnés au culte du veau d'or. Au cours des siècles, nombre de chrétiens ou philosophes ont rejeté tout ou partie de l'Ancien Testament à cause de ces traits divins qui ne concordent pas, loin s'en faut, avec certaines images du Dieu bon et doux du Nouveau Testament. Alors, peut-on aujourd'hui croire ou (re)croire à un Dieu macho, cruel, despotique ou même purificateur ethnique ? Thomas Römer propose de relire les passages litigieux à la lumière des dernières recherches en Ancien Testament. Pour l'auteur, les traits à première vue rébarbatifs que Dieu arbore ici et là veulent préserver la foi de tout ronron dogmatique en lui instillant les visions inattendues d'un Dieu en prise avec la vie réelle de l'humanité. Cet ouvrage est une réédition largement revue et augmentée de l'ancienne version parue 1996. Il accueille un nouveau chapitre sur le Dieu moralisateur et l'homme pécheur.

Ceftriaxone--bilirubin-albumin interactions in the neonate: an in vivo study.

The in vivo bilirubin-albumin binding interaction of ceftriaxone (CRO) was investigated in 14 non-jaundiced newborns, aged 33-42 weeks of gestation, during the first few days of life after they had reached stable clinical condition. CRO (50 mg/kg) was infused intravenously over 30 min. The competitive binding effect of CRO on the bilirubin-albumin complex was estimated by determining the reserve albumin concentration (RAC) at baseline, at the end of CRO infusion, and at 15 and 60 min thereafter. Immediately after the end of drug administration, RAC decreased from 91.9 (+/- 25.1) mumol/l to 38.6 (+/- 10.1) mumol/l (P = 0.0001). At the same time the plasma bilirubin toxicity index (PBTI) increased from 0.64 (+/- 0.40) before drug infusion to 0.96 (+/- 0.44) thereafter (P = 0.0001). The highest displacement factor (DF) was calculated to be 2.8 (+/- 0.6) at the end of drug infusion. Average total serum bilirubin concentrations decreased from a baseline value of 59.6 (+/- 27.0) mumol/l to 55.2 (+/- 27.1) mumol/l (P = 0.026). Sixty minutes after the end of CRO infusion, RAC was 58.3 (+/- 21.7) mumol/l, PBTI regained baseline, but DF was still 1.9 (+/- 0.2). No adverse events were recorded. Our results demonstrate significant competitive interaction of CRO with bilirubin-albumin binding in vivo. Thus, ceftriaxone should not be given to the neonate at risk of developing bilirubin encephalopathy.

Les Chalcidiens (Hymenoptera, Chalcidoidea) associés au genre Ficus spp. (Moracee) du Sénégal : répartition, abondance et diversité

Cette étude est la première portant sur la biodiversité écologique des Chalcidiens associés au genre Ficus au Sénégal. Sur les 26 espèces de figuiers signalées au Sénégal, 11 ont été trouvées. Chaque espèce de Ficus possède une microfaune Chalcidienne caractéristique. La comparaison des niveaux d'infestation révèle une différence très significative entre espèces de Ficus (P<0.0001). Les figues de F.sycomorus du domaine Nord-Soudanien sont, en valeurs absolues, plus infestées que celles des domaines Sud-Soudanien et Soudanien Atlantique. Les tests statistiques révèlent une différence d'infestation non significative des figues de F.sycomorus entre les 3 domaines (P>0.05). Cependant, entre le domaine Nord-Soudanien et le domaine Soudanien Atlantique, cette différence est significative (P=0.0091).